Seroprevalence of Hepatitis B Infection During Pregnancy and Risk of Perinatal Transmission
Overview
Authors
Affiliations
Objectives: To investigate the seroprevalence of hepatitis B surface antigen (HBsAg) in pregnant women and possible risk factors for perinatal hepatitis B virus (HBV) transmission.
Methods: Four thousand pregnant women were evaluated using history, examination, and test for serum HBsAg using commercial enzyme immunoassay kits. For HBsAg positive women, liver function tests and a test for hepatitis B e antigen (HBeAg) was done. HBV DNA analysis was done by polymerase chain reaction (PCR).
Results: Of 4,000 women studied, 37 (0.9%) tested positive for HBsAg. Of these 37 women, 6 (16%) presented with acute hepatitis and 31 (84%) were asymptomatic. The highest HBsAg positivity rate was seen in the age group of 21-25 years (1.15%) followed by 26-30 years (0.86%). Assessment of risk factors revealed history of tattooing in 29/37 (78.4%) women. HBeAg was positive in 21 of 37 (56.8%) women. Of the 16 HBeAg negative women, 5 were positive for HBV DNA and anti-HBe antibody, 6 had only anti-HBe antibody and 5 had neither HBV DNA nor anti-HBe. Vertical transmission was seen in 65% (13/20) of babies born to mothers who were positive for HBeAg and HBV DNA. In contrast, it was only 9.1% (1/11) for babies born to mothers who were negative for both HBeAg and HBV DNA. Of the 25 babies delivered vaginally, 15 (60%) developed vertical transmission. None of the four babies delivered by elective cesarean section had evidence of vertical transmission.
Conclusions: Seroprevalence of HBsAg in antenatal women was found to be 0.9%. HBe-antigen and HBV DNA positivity was associated with a higher chance of vertical transmission.
Roiji B, Roiji A, Adewara O, Yusuf M, Durojaye O, Adeniyi O Pan Afr Med J. 2025; 49:55.
PMID: 39911365 PMC: 11795117. DOI: 10.11604/pamj.2024.49.55.45111.
Vertical Transmission of Hepatitis B Virus-An Update.
di Filippo Villa D, Navas M Microorganisms. 2023; 11(5).
PMID: 37317114 PMC: 10221798. DOI: 10.3390/microorganisms11051140.
Giri S, Sahoo S, Angadi S, Afzalpurkar S, Sundaram S, Bhrugumalla S J Clin Exp Hepatol. 2022; 12(6):1408-1419.
PMID: 36340309 PMC: 9630021. DOI: 10.1016/j.jceh.2022.08.005.
Wang N, Zheng J, Huang Y, Pu X, Jiang L, Yang J Medicina (Kaunas). 2022; 58(9).
PMID: 36143956 PMC: 9500857. DOI: 10.3390/medicina58091279.
Utami D, Chalid M, Masadah R, Sjahril R, Bahagia Febriani A Interdiscip Perspect Infect Dis. 2022; 2022:4838376.
PMID: 35875205 PMC: 9300366. DOI: 10.1155/2022/4838376.